National Institutes of Health
Clinical Research Network on Antimicrobial Resistance (UM1 Clinical Trial Required)
Clinical Research Network on Antimicrobial Resistance (UM1 Clinical Trial Required) is a funding opportunity from National Institutes of Health, closing September 29, 2026.
Overview
The National Institute of Allergy and Infectious Diseases (NIAID) seeks to advance its mission by continuing support for a Clinical Research Network on Antimicrobial Resistance (AMR). AMR is a major health challenge that limits treatment options and allows resistant infections to persist. Individuals with chronic…